Exchange & Returns Information


(5)
| Generic For | ULTIBRO BREEZHALER |
|---|---|
| Active Ingredient | INDACATEROL|GLYCOPYRRONIUM |
| Strength | 110MCG|50MCG |
| Manufacturer | UNILAB |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| ★ Best Value 1 BOX - 30 CAPSULES | $ 2.63 | $ 79.00 |
$ 67.15
Apply ZARVY26 (-15%)
You save $ 11.85
|
||
| ★ Best Value 2 BOXES - 60 CAPSULES | $ 2.47 |
6% $ 158.00
$ 148.00
|
$ 125.80
Apply ZARVY26 (-15%)
You save $ 22.20
|
||
| ★ Best Value 3 BOXES - 90 CAPSULES | $ 2.27 |
14% $ 237.00
$ 204.00
|
$ 173.40
Apply ZARVY26 (-15%)
You save $ 30.60
|


Reference information will be available soon.
Glycoair Breezhaler 110/50 mcg is a generic inhalation capsule combining Indacaterol (110mcg) and Glycopyrronium (50mcg), designed to provide dual bronchodilation for individuals suffering from chronic obstructive pulmonary disease (COPD) and moderate to severe asthma. Indacaterol acts as a long-acting beta2-adrenergic agonist (LABA), promoting sustained bronchial muscle relaxation, while Glycopyrronium is a long-acting muscarinic antagonist (LAMA) that blocks acetylcholine-induced bronchoconstriction. Together, these two agents synergize to provide prolonged airway dilation, ease of breathing, and significant reduction in respiratory symptoms. This inhaler is particularly useful in patients experiencing bronchitis, asthma/COPD overlap, or post-viral airway reactivity. It may also offer secondary symptomatic relief in respiratory conditions such as post-influenza bronchospasm or lingering airway constriction after tonsillitis, even though it is not a direct antimicrobial agent. It belongs to the Respiratory Diseases category under the subcategories Asthma / COPD and Bronchitis.
Asthma / COPD Combines long-acting β2-agonist (Indacaterol) and long-acting muscarinic antagonist (Glycopyrronium) to provide dual bronchodilation, improving airflow, reducing breathlessness, and enhancing daily activity tolerance in patients with chronic obstructive pulmonary disease (COPD) and persistent asthma. Bronchitis Helps relieve symptoms of chronic and acute bronchitis, including airway inflammation, mucus overproduction, and wheezing, promoting easier breathing. Flu (Influenza) & Colds May aid in relieving lingering bronchial constriction and improving breathing comfort following viral respiratory infections such as influenza or colds. Tonsillitis (Supportive) While not a primary treatment, it can offer supportive respiratory relief when airway discomfort persists after upper respiratory tract infections. ✔ Intended for regular maintenance therapy, not for acute symptom relief. ✔ Always use under medical supervision for chronic respiratory management.
- Bronchodilation: Offers long-acting relaxation of airway smooth muscles, providing 24-hour symptom control. - Anti-cholinergic Action: Glycopyrronium reduces mucus secretion and improves airflow by inhibiting muscarinic receptors. - Synergistic Effect: Indacaterol and Glycopyrronium work via complementary mechanisms, resulting in improved lung function and symptom relief. - Symptom Management: Reduces wheezing, coughing, shortness of breath, and the frequency of exacerbations in COPD.
For Respiratory Diseases > Asthma / COPD - Use one Glycoair Breezhaler 110/50 mcg capsule daily with the Breezhaler inhalation device, as prescribed by your doctor. - Insert the capsule into the chamber, pierce it using the device, and inhale the medication deeply through the mouthpiece. - Do not swallow the capsule, as it is intended for inhalation use only. - Use the inhaler at the same time every day to maintain consistent bronchodilation and symptom control. - Rinse your mouth after use to minimize the risk of oral irritation or dryness. - This combination of Indacaterol and Glycopyrronium is designed for long-term maintenance therapy and should not be used for acute symptom relief. For Respiratory Diseases > Bronchitis - Administer one Glycoair Breezhaler 110/50 mcg capsule daily using the Breezhaler device to manage chronic bronchitis symptoms. - Place the capsule into the inhaler chamber, pierce it, and inhale the contents deeply through the mouth to ensure proper drug delivery to the lungs. - Avoid swallowing the capsule; it is strictly for inhalation use. - Use the medication consistently at the same time each day to achieve sustained improvement in airflow and reduce symptom exacerbation. - After inhalation, rinse your mouth thoroughly to help prevent dry mouth or irritation. - Consult your healthcare provider if symptoms persist or worsen despite regular use.
- Store at room temperature below 25°C, away from moisture and direct sunlight. - Keep the capsules in their original packaging until use to protect from humidity. - Do not freeze or refrigerate. - Keep out of reach of children.
- Common: Dry mouth, cough, headache, sore throat. - Less common: Palpitations, dizziness, tremors, urinary retention. - Rare: Hypersensitivity reactions such as rash or swelling. Seek medical attention if breathing worsens or serious allergic symptoms appear.
Reviewed by 5 Users
Write a Review:
✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.
✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.
💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.
Multiple orders:
✓ If you bought this product more than once on different days, you can write a separate review for each order.
💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.
Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.
Stable performance for a daily inhaler.
Breezhaler works well, easy setup.
Compact enough for everyday carry.
Works well and feels comfortable to use. Nothing inconvenient so far.
Keeps symptoms in check with no hassle.
No combo deals available at the moment.
Loading...
Loading...
Loading...